Fulgent Genetics (FRA:7F0) Tariff Resilience Score: 8/10 (As of Jul. 05, 2026)


FRA:7F0 Fulgent Genetics Inc FRA:7F0
64 GF Score
Price €18.10
GF Value €20.87
! 4 Warning Signs
View Full Analysis

What is Fulgent Genetics Tariff Resilience Score?

Fulgent Genetics FRA:7F0 -0.55% 64 Tariff Resilience Score is 8 as of Jul. 05, 2026. GuruFocus rates FRA:7F0 with a GF Score™ of 64/100 and a GF Value™ of €20.87. The stock has 4 warning signs investors should review. Among 216 Medical Diagnostics & Research companies, Fulgent Genetics ranks better than 98.15% on this metric.

Fulgent Genetics has the Tariff Resilience Score of 8, which implies that the company might have Highly Resilient.

Fulgent Genetics has Fulgent Genetics primarily operates in the healthcare sector with limited exposure to international tariffs. Its supply chain is largely domestic, and its services are not heavily reliant on imported goods, providing resilience against tariff impacts.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Fulgent Genetics might have Highly Resilient.


Fulgent Genetics  (FRA:7F0) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Fulgent Genetics Tariff Resilience Score Related Terms


FRA:7F0 vs MYGN, CSTL, BDSX: Tariff Resilience Score Comparison

For the Diagnostics & Research subindustry, Fulgent Genetics's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fulgent Genetics Tariff Resilience Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Fulgent Genetics's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Fulgent Genetics's Tariff Resilience Score falls into.


FRA:7F0
64GF Score
Fulgent Genetics Inc FRA:7F0
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 8 mean?
Fulgent Genetics (FRA:7F0) has a Tariff Resilience Score of 8 as of Jul. 05, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Fulgent Genetics ranks #4 out of 216 companies in the Medical Diagnostics & Research industry, placing it in the top 1.9%.
Is Fulgent Genetics' Tariff Resilience Score too high?
Fulgent Genetics' current Tariff Resilience Score is 8. Based on the distribution chart, Fulgent Genetics ranks #4 out of 216 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Fulgent Genetics has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.
How does Fulgent Genetics' Tariff Resilience Score compare to MYGN and CSTL?
According to the Medical Diagnostics & Research industry distribution chart, Fulgent Genetics ranks #4 out of 216 companies for Tariff Resilience Score. This places Fulgent Genetics in the top 2% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Diagnostics & Research company?
A good Tariff Resilience Score depends on the Medical Diagnostics & Research industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Fulgent Genetics's current Tariff Resilience Score is 8. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fulgent Genetics stock overvalued right now?
Fulgent Genetics (FRA:7F0) has a current Tariff Resilience Score of 8. The stock's GF Value™ is €20.87, compared to a current price of €18.10 — trading 13.3% below its estimated fair value. The current Tariff Resilience Score is 8. Fulgent Genetics' overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Fulgent Genetics (FRA:7F0), the current Tariff Resilience Score is 8 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fulgent Genetics (FRA:7F0) Overvalued in 2026?

Based on GuruFocus' analysis, Fulgent Genetics stock appears to be undervalued. The current stock price of €18.10 is trading 13.3% below its estimated GF Value™ of €20.87.

Key valuation signals for FRA:7F0:

  • Tariff Resilience Score: 8
  • GF Value™: €20.87 vs. price of €18.10 (13.3% below fair value)
  • GF Score™: 64/100 with 4 warning signs

No single metric tells the full story. See the FRA:7F0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fulgent Genetics Business Description

Other Exchanges FLGT:USAFLGT:Mexico
Address 4399 Santa Anita Avenue, El Monte, CA, USA, 91731
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.
64GF Score

Get the complete analysis for FRA:7F0

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€18.10
Price
€20.87
GF Value